Daniel Lipinski, MSc, DPhil
Departments of Ophthalmology & Visual Sciences; Cell Biology Neurobiology and Anatomy; Medical College of Wisconsin
Associate Professor
Medical College of Wisconsin
Eye Institute, 7th Floor
925 N. 87th St
Milwaukee, WI 53226
Office: +1 414-955-2062
Biography
Education
D. Phil. Ophthalmology, University of Oxford, Oxford, UK (2009 – 2012)
M. Sc. Molecular Biology and Pathology of Viruses, Imperial College London, UK (2008 – 2009)
B. Sc. Biology, Imperial College London, UK (2005 – 2008)
Research
Dr. Lipinski’s interest lies in the development of safe and effective gene therapy treatments to prevent vision loss in people who have inherited or vascular diseases affecting their eye. To this end, his research focuses on the engineering of recombinant adeno-associated virus (rAAV) vectors to target cells of the retina and ocular vasculature, the elucidation of novel gene-based therapeutics to prevent cone photoreceptor loss or vascular dysfunction, and the evaluation of strategies to restore vision to the degenerate retina. He is particularly interested in establishing collaborators at UW–Madison, including providing purified rAAV vectors for vision research applications.